| 2024-02-12 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 781 0.0007% | $67.77 | $52,926 | -27.14% | |
| 2024-01-29 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 906 0.0008% | $64.14 | $58,109 | -19.54% | |
| 2024-01-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 4,184 0.0035% | $65.00 | $271,943 | -15.29% | |
| 2024-01-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 4,240 0.0036% | $66.81 | $283,268 | -16.92% | |
| 2023-12-19 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 3,905 0.0032% | $57.23 | $223,472 | -2.58% | |
| 2023-07-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 8,510 0.0075% | $89.98 | $765,730 | -46% | |
| 2022-06-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 20,000 0.019% | $44.51 | $890,280 | +36.02% | |
| 2022-04-25 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 5,000 0.0047% | $50.00 | $250,000 | +7.29% | |
| 2022-04-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 5,000 0.0046% | $50.00 | $250,000 | +3.91% | |
| 2021-12-27 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 2,400 0.0028% | $48.50 | $116,400 | +2.06% | |
| 2021-12-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 21,142 0.0247% | $47.81 | $1.01M | +1.92% | |
| 2020-12-14 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 16,796 0.0224% | $52.12 | $875,421 | -10.38% | |
| 2020-12-11 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 19,870 0.0176% | $31.93 | $634,350 | -2.51% | |
| 2020-02-10 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 10,000 0.0136% | $44.50 | $445,000 | -25.54% | |
| 2020-01-27 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 6,000 0.0082% | $40.47 | $242,802 | -18.23% | |
| 2018-09-14 | Sale | Apellis Pharmaceuticals, Inc. APLS | General Counsel | 31,552 0.057% | $18.78 | $592,673 | +1.57% |